Market Overview:
The global escin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. Escin is a natural product obtained from the horse chestnut tree, and it has been used for medicinal purposes for centuries. The main application of escin is in the treatment of venous diseases, but it also has anti-inflammatory, anti-edematous, and anti-nociceptive properties. Escin is available as a more than 98% pure product or as an extract with various levels of purity. It is mainly marketed as an over-the-counter (OTC) medication for the treatment of venous diseases, but there are some prescription products available in some countries.
Product Definition:
Escin is a mixture of saponins found in the bark and leaves of horse chestnut trees. Escin has anti-inflammatory, antioxidant, and venotonic properties.
More than 98%:
More than 98% is a term used for indicating the percentage by which the quantity of a product, solution or compound exceeds 98%. It is also known as percent more or plus percent. More than 98% can be represented by % “+” sign. For instance, if 100 g of substance A and 200 g of substance B are mixed together and 100 g more is obtained then it would be said that mixture contains 99.98% of substances A & B i.e.
Less Than 98%:
Escin is a form of hydroxyapatite. It is used as an injectable material for bone reconstruction and also used in the treatment of osteoporosis. Less than 98% purity can be injected into the body to treat conditions like osteoporosis, which causes weak bones or fractures easily.
Application Insights:
Vasoprotective anti-inflammatory agent was the leading application segment in current scenario and is projected to maintain its dominance over the forecast period. Escin has been used as a protective agent against acute lung injury, which occurs due escin¢â‚¬â„¢s ability to reduce inflammation. It also displays antioxidant properties that help in protecting cells from damage caused by free radicals. These characteristics have led to its extensive use as a vasoprotective anti-inflammatory agent across various applications such escin cream for osteoarthritis treatment or oral tablets for rheumatoid arthritis patients.
Anti-edematous Agent is expected to be the fastest growing application segment with CAGR of XX% during forecast years owing to increasing usage of escin products for treating edema associated diseases such as hypertension, heart failure and liver disease among others.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing product demand from various application sectors, such as veterinary and human medicine. In addition, rising prevalence of chronic diseases coupled with high healthcare expenditure is also one of the major factors contributing toward regional growth.
Asia Pacific is anticipated to be one of the fastest-growing regions over a forecast period owing to rapid economic development coupled with growing consumer disposable income levels in emerging countries such as China and India. Furthermore, government initiatives for improving public health are also expected favorably impact regional market growth over the next eight years.
Growth Factors:
- Escin is a natural product and it is considered to be safe for human use. This factor is likely to drive the growth of the escin market in the coming years.
- Escin has anti-inflammatory and analgesic properties, which make it an effective treatment for various medical conditions such as venous insufficiency, hemorrhoids, and varicose veins. This is another factor that is expected to fuel the growth of the escin market in future.
- Escin helps improve blood circulation and reduce edema or swelling caused by injury or surgery. This property of escin makes it an important ingredient in many cosmetic products such as anti-cellulite creams and lotions. The increasing demand for these products is likely to boost the growth of the escin market in future years
Scope Of The Report
Report Attributes
Report Details
Report Title
Escin Market Research Report
By Type
More than 98%, Less Than 98%
By Application
Vasoprotective Anti-Inflammatory Agent, Anti-Edematous Agent, Anti-Nociceptive Agent
By Companies
BOC Sciences, Merck, EXTRASYNTHESE, ApexBio Technology, Chengdu Must Bio-Technology, BioCrick BioTech, AdooQ BioScience, ChemScence, Pharmaffiliates, Galen-N
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Escin Market Report Segments:
The global Escin market is segmented on the basis of:
Types
More than 98%, Less Than 98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vasoprotective Anti-Inflammatory Agent, Anti-Edematous Agent, Anti-Nociceptive Agent
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- Merck
- EXTRASYNTHESE
- ApexBio Technology
- Chengdu Must Bio-Technology
- BioCrick BioTech
- AdooQ BioScience
- ChemScence
- Pharmaffiliates
- Galen-N
Highlights of The Escin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- More than 98%
- Less Than 98%
- By Application:
- Vasoprotective Anti-Inflammatory Agent
- Anti-Edematous Agent
- Anti-Nociceptive Agent
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Escin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Escin is a medication used to treat high blood pressure. It works by lowering blood pressure by widening the arteries and reducing the amount of fluid that flows through them.
Some of the major players in the escin market are BOC Sciences, Merck, EXTRASYNTHESE, ApexBio Technology, Chengdu Must Bio-Technology, BioCrick BioTech, AdooQ BioScience, ChemScence, Pharmaffiliates, Galen-N.
The escin market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Escin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Escin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Escin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Escin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Escin Market Size & Forecast, 2020-2028
4.5.1 Escin Market Size and Y-o-Y Growth
4.5.2 Escin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 More than 98%
5.2.2 Less Than 98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Vasoprotective Anti-Inflammatory Agent
6.2.2 Anti-Edematous Agent
6.2.3 Anti-Nociceptive Agent
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Escin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Escin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 More than 98%
9.6.2 Less Than 98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Vasoprotective Anti-Inflammatory Agent
9.10.2 Anti-Edematous Agent
9.10.3 Anti-Nociceptive Agent
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 More than 98%
10.6.2 Less Than 98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Vasoprotective Anti-Inflammatory Agent
10.10.2 Anti-Edematous Agent
10.10.3 Anti-Nociceptive Agent
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 More than 98%
11.6.2 Less Than 98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Vasoprotective Anti-Inflammatory Agent
11.10.2 Anti-Edematous Agent
11.10.3 Anti-Nociceptive Agent
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 More than 98%
12.6.2 Less Than 98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Vasoprotective Anti-Inflammatory Agent
12.10.2 Anti-Edematous Agent
12.10.3 Anti-Nociceptive Agent
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 More than 98%
13.6.2 Less Than 98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Vasoprotective Anti-Inflammatory Agent
13.10.2 Anti-Edematous Agent
13.10.3 Anti-Nociceptive Agent
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Escin Market: Competitive Dashboard
14.2 Global Escin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BOC Sciences
14.3.2 Merck
14.3.3 EXTRASYNTHESE
14.3.4 ApexBio Technology
14.3.5 Chengdu Must Bio-Technology
14.3.6 BioCrick BioTech
14.3.7 AdooQ BioScience
14.3.8 ChemScence
14.3.9 Pharmaffiliates
14.3.10 Galen-N
